STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...Middle East

STORM's first-in-class investigational drug STC-15 is the first clinical stage molecule specifically targeting an RNA methyltransferase STC-15 reshapes the tumour microenvironment and activates anti-tumour immunity CAMBRIDGE, UK, Oct. 17, 2023 /PRNewswire/ -- STORM Therapeutics Ltd....

Hence then, the article about storm therapeutics presented novel pre clinical data on stc 15 at the aacr nci eortc international conference on molecular targets and cancer therapeutics was published today ( Tuesday 17/10/2023 - 10:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics )

Also on site :

• Former presidents reflect on America at 250: ‘Constant work in progress’
• Saturday evening weather forecast - July 4, 2026
• Storm threat triggers chaotic evacuation ahead of Trump’s speech (VIDEOS)